Experience with the laws impacting the commercial business operations of pharmaceutical and device companies, including the Antikickback Statute, the False Claims Act (FCA), the Food, Drug & Cosmetic Act (FDCA), the Medicaid Statute (Title XIX of the Social Security Act), the Inflation Reduction Act (IRA), and the Affordable Care Act (ACA). Advising on FDA laws and regulations, anti-kickback and bribery statutes, false claims acts, transparency laws (federal and state on TOV, and state pricing transparency), the Health Insurance Portability and Accountability Act (HIPAA), state privacy laws and other relevant laws and regulations governing the commercialization of pharmaceutical products in both the US and international jurisdictions.